Bioneer Corporation
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analys… Read more
Bioneer Corporation (064550) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.004x
Based on the latest financial reports, Bioneer Corporation (064550) has a cash flow conversion efficiency ratio of 0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩860.54 Million) by net assets (₩229.21 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioneer Corporation - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Bioneer Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioneer Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioneer Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Savior Lifetec
TWO:4167
|
0.028x |
|
CRAWFORD + CO. A NV
F:CWK0
|
N/A |
|
Iones Co. Ltd
KQ:114810
|
0.014x |
|
Sovereign Metals Limited
OTCQX:SVMLF
|
-0.114x |
|
First Savings Financial Group Inc
NASDAQ:FSFG
|
0.544x |
|
29METALS Ltd
AU:29M
|
0.051x |
|
Shenzhen Riland Industry Co
SHE:300154
|
0.062x |
|
Wintao Communications Co. Ltd
SHE:301139
|
0.002x |
Annual Cash Flow Conversion Efficiency for Bioneer Corporation (2014–2024)
The table below shows the annual cash flow conversion efficiency of Bioneer Corporation from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩226.89 Billion | ₩-13.48 Billion | -0.059x | -437.31% |
| 2023-12-31 | ₩234.88 Billion | ₩4.14 Billion | 0.018x | -52.80% |
| 2022-12-31 | ₩236.00 Billion | ₩8.81 Billion | 0.037x | -85.75% |
| 2021-12-31 | ₩203.05 Billion | ₩53.17 Billion | 0.262x | -60.16% |
| 2020-12-31 | ₩145.61 Billion | ₩95.71 Billion | 0.657x | +459.95% |
| 2019-12-31 | ₩30.61 Billion | ₩-5.59 Billion | -0.183x | +12.25% |
| 2018-12-31 | ₩38.99 Billion | ₩-8.11 Billion | -0.208x | -44.77% |
| 2017-12-31 | ₩27.15 Billion | ₩-3.90 Billion | -0.144x | +8.26% |
| 2016-12-31 | ₩26.11 Billion | ₩-4.09 Billion | -0.157x | -1427.23% |
| 2015-12-31 | ₩34.53 Billion | ₩407.68 Million | 0.012x | +108.26% |
| 2014-12-31 | ₩30.20 Billion | ₩-4.31 Billion | -0.143x | -- |